Chief Executive Officer

WORK EXPERIENCE:

2015 - Present
Co-founder and General Manager of Wellmicro Sri.
A company operating in the field of biotechnology applied to human health, with a particular focus
on the impact of microbial ecology (microbiome) on host health.
2010-2014
Co.co.pro. at the Novartis Vaccines Sri Research Center in Siena
Research activity carried out for the development of the vaccine against Streptococcus agalactiae

PROFESSIONAL QUALIFICATIONS:

2025 - Present
Member of the scientific committee of the Italian Biologists Foundation (FIB)
2016 - Present
Qualified to practice as a biologist after passing the state exam and registered in the professional register
of the Order of Biologists of Emilia-Romagna and Marche (registration no. ERM_A3135)

EDUCATION:

2015-2016
Research fellow at the Department of Pharmacy and Biotechnology (FaBiT) of Alma Mater Studiorum - University of Bologna.
Project in Microbiology applied to the study of the effects of prebiotic compounds on the human intestinal microbiota.
2010-2014
Doctoral School in Biotechnology, 26th cycle, administrative headquarters at the University of Siena, Siena.
Research conducted at the Novartis Vaccines Sri Research Center in Siena.
Project in Molecular Biotechnology
PhD degree obtained on December 18, 2014
Tutors: Prof. Cosima Baldari and Dr. Domenico Maione
Thesis: "A new mobile genetic element for studying a streptococcal type IV secretion system in bacterial
conjugation"
2007 - 2010
Master's Degree in Molecular and Cellular Biology
“Alma Mater Studiorum,” University of Bologna, Bologna
Final degree score: 110/110 cum laude
Experimental thesis carried out at the Lions Eye Institute, Western Australia, Perth (Australia) from May 2009 to February 2010
Supervisor: Prof. Renato Brandimarti.
Title: “Creation of recombinant MCMV to investigate the viral apoptotic inhibition by BAC recombineering”